Breaking

The Broad Institute of MIT and Harvard, known for its groundbreaking biotech research, recently made the decision to lay off 87 employees. This move comes as the institute undergoes some restructuring within its teams....

Jasper Therapeutics, a biotech company focusing on improving stem cell transplants and treating immune-mediated diseases, shared positive results from an initial clinical trial of its experimental drug for a chronic skin condition. The drug,...

Biotech investors have been showing a lot of interest in the field of autoimmune diseases this year. While the obesity market is also attracting attention, autoimmune conditions have been at the forefront of drug...

SalioGen Therapeutics, a biotech company that secured $135 million in funding to develop a cutting-edge gene-editing technology, is facing a challenging situation as it recently laid off a significant number of employees and adjusted...

As the week comes to a close, many of us are looking forward to the weekend. Whether it's spending time with family, enjoying the outdoors, or simply relaxing, we all have our own plans....

Imagine a world where your elderly mother could receive quality care at home without bankrupting your family. Now picture that same world, but with a twist: The caregiver isn’t a typical home care worker,...

First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others.“To encourage robust, good-faith discussion about issues raised...

Vice President Kamala Harris has recently received a positive health report, indicating that she is in excellent health and possesses the physical and mental resilience needed to serve as president. The report was released...

Sanofi, a French drugmaker, is in talks to sell a 50% stake in its consumer health business, Opella, for $16 billion to a U.S. private equity firm. Camp4 Therapeutics raised $75 million in an...

The Food and Drug Administration, or FDA, announced on Friday that it would be revisiting its decision to remove Eli Lilly's tirzepatide, which is known as Mounjaro for diabetes and Zepbound for obesity, from...

Since the Nobel Prizes were established in 1901, only 24 women have been recognized in the field of science. This year, the trend continued as all seven laureates in physics, chemistry, and physiology or...

Pharmalot Columnist, Senior WriterHave you recently hired a new and exciting employee? Promoted a rising star within your company? Finally filled a challenging position? Don't keep it to yourself - share the news with...

The battle over blockbuster weight loss medications is intensifying, and patients are finding themselves caught in the middle. The Food and Drug Administration recently announced the end of the shortage of Eli Lilly's tirzepatide,...

Teva Pharmaceuticals recently reached a significant settlement agreement, agreeing to pay a total of $450 million to address allegations of engaging in kickbacks and price-fixing. This settlement marks the largest of its kind and...

John Maraganore, a well-known figure in the biotech industry, recently discussed his involvement in the innovative RNAi startup, City Therapeutics, on the latest episode of STAT's biotech podcast, "The Readout LOUD." Maraganore shared insights...

A recent analysis revealed that nearly 60% of experts who reviewed manuscripts for four major medical journals received payments from the industry. The study, conducted over a three-year period, found that these reviewers and...

Bill Nye, best known as the Science Guy, has shifted his focus to bring attention to ataxia, a neurological disease that has impacted his family for generations. He has teamed up with the National...

Late Tuesday night, Carequality revealed new details about the ongoing dispute between electronic health records giant Epic Systems and health data startup Particle Health. The conflict has now escalated to the point of an...

Bluebird Bio's gene therapy, known as Skysona, has been linked to the development of blood cancers in seven out of 67 children who received the treatment for a severe neurological disorder in clinical trials....

Good day to all our readers, we hope you are having a productive week so far. As we look forward to the weekend, let's stay focused and keep pushing forward. Today, we suggest enjoying...

Ultragenyx's founder and CEO, Kakkis, is at the forefront of developing another treatment for an ultra-rare disease called Barth syndrome. This genetic disorder affects around 200 boys worldwide and is caused by a mutation...

ViiV Healthcare recently announced plans to increase access to its HIV prevention medication in low- and middle-income countries. This marks the second time in two years that the company has taken such steps. Despite...

On Tuesday, Mark Cuban, the billionaire business mogul, seemed to have insider information about Vice President Harris' presidential campaign's proposal to crack down on middlemen in the pharmaceutical industry. The campaign announcement coincided with...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds.Why do bad menstrual cramps happen to good people? A study answering that question would get the Gaffney Prize...

Scholar Rock, a biotech company, announced on Monday that their new drug has shown promising results in a late-stage study for spinal muscular atrophy. The drug, called apitegromab, was tested in a year-long Phase...

Georgina Peacock shared a poignant memory of a night during her pediatric medical training when she admitted 20 babies struggling to breathe due to Respiratory Syncytial Virus (RSV). Since then, efforts have been relentless...

Sammy Basso, a well-known advocate for progeria patients, passed away at the age of 28. Despite the challenges he faced due to his genetic disorder, Sammy was known for his ability to find humor...

Good morning! This is Adam Feuerstein reporting from the Pharmalittle campus in Cambridge, Mass., filling in for our regular host Ed. Like Mr. Pharmalot, I start my day with a cup of coffee and...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Today’s item on bacterial outbreaks linked to hospital ice machines reminded me of The National’s song...

Today, let's discuss the possibility of AI taking over cancer research, WuXi's decision to sell some of its operations due to the BIOSECURE Act, and more exciting news in the biotech world.AI in Cancer...